Showing results (251-260 of 672) with videos related to
Sort By:
Pageof 68
Fortschritte Der Neurologie-Psychiatrie|March 27, 1999
[Frontal lobe dementia. Clinical-pathologic case reports]C Zachhuber, F Leblhuber, C Bancher, et al.Zeitschrift Fur Gerontologie Und Geriatrie|January 1, 1997
[Histopathologic studies in dementia--comparison with clinical findings]C Zachhuber, F Leblhuber, K Jellinger, et al.Acta Neuropathologica|January 1, 1988
Reactivity of circulating antineuronal antibodies (CANA) on peripheral nervous system structuresW Grisold, M Drlicek, U Liszka, et al.Journal of Neurology|January 1, 1979
The symptomatology with the most severe clinical course of spontaneous subarachnoid hemorrhageH Binder, F Gerstenbrand, K Jellinger, et al.European Journal of Neurology|August 28, 2003
Guillain-Barré syndrome with marked pleocytosis or a significant proportion of polymorphonuclear granulocytes in the cerebrospinal fluid: neuropathological investigation of five cases and review of differential diagnosesH Rauschka, K Jellinger, H Lassmann, et al.European Neurology|January 1, 1990
Dopamine uptake sites and dopamine receptors in Parkinson's disease and schizophreniaR K Pearce, P Seeman, K Jellinger, et al.Journal of Neuropathology and Experimental Neurology|May 22, 1998
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosisC Stadelmann, W Brück, C Bancher, et al.Psychopathology|January 1, 1987
Biochemical aspects of dysphoria: case study for hypothesis generationP Kruzik, E Sofic, P Riederer, et al.Journal of Neural Transmission. Supplementum|December 16, 1998
Free radicals in Alzheimer's dementia: currently available therapeutic strategiesM Rösler, W Retz, J Thome, et al.Psychiatry Research|September 1, 1988
Endocrine parameters and biogenic amines in relationship to psychopathology after cholinergic drug challenge (RS-86)J Fritze, E Sofic, P Riederer, et al.Pageof 68